Zobrazeno 1 - 10
of 35
pro vyhledávání: '"K, Rerat"'
Autor:
J, Dupouy, F, Ory-Magne, C, Mekies, V, Rousseau, M, Puel, K, Rerat, J, Pariente, C, Brefel-Courbon, E, Vidry
Publikováno v:
Acta Neurologica Scandinavica. 137:59-66
Background Subjective cognitive complaint (SCC) is a criterion recommended by the Movement Disorder Society (MDS) task force for the diagnosis of mild cognitive impairment (MCI). Until now there were few specific tools for detecting SCC in PD. We sou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd5cef06dc0d86f00841cdd8abafd51
https://doi.org/10.1111/ane.12808
https://doi.org/10.1111/ane.12808
Autor:
Christian Denier, Ombeline Fagniez, David Adams, Catherine Lacroix, K Rerat, Marie Théaudin, Aissatou Signate, P. Lozeron, P Corcia
Publikováno v:
Amyloid. 18:98-100
In order to define clinical patterns of light-chain amyloid (AL) polyneuropathy, we reviewed the data of 24 patients. At diagnosis, the mean duration of the symptoms was 21 months (range,...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c514b3bab68324ca1d9b2e68fc7886f
https://doi.org/10.3109/13506129.2011.574354036
https://doi.org/10.3109/13506129.2011.574354036
Publikováno v:
Journal of the neurological sciences. 350(1-2)
Background Neurofibromatosis 1 (NF1) belongs to the autosomal dominant neurocutaneous disorders' group, which mainly includes NF1 and NF2, tuberous sclerosis, von Hippel-Lindau disease and Cerebral Cavernous Malformations (CCMs). NF1 has a major impa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adf4ce44c5adcb0ac7efbe81e4775dea
https://pubmed.ncbi.nlm.nih.gov/25702150
https://pubmed.ncbi.nlm.nih.gov/25702150
Autor:
K Rerat, Patrick Vermersch, E Masy, U. Michon-Pasturel, E. Hachulla, M.A. Cordoliani, J Arvieux
Publikováno v:
La Revue de Médecine Interne. 19:635-639
Resume Propos Bien que la sclerose en plaques (SEP) et le syndrome primaire des antiphospholipides soient habituellement definis selon des criteres specifiques qui permettent de les distinguer, dans certains cas la transition entre les deux maladies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c5a0977fe22fb440feec650fbe1785b
https://doi.org/10.1016/s0248-8663(99)80042-3
https://doi.org/10.1016/s0248-8663(99)80042-3
Publikováno v:
European journal of neurology. 15(7)
Levodopa is the gold standard drug for the symptomatic control of Parkinson's disease (PD). However, long-term treatment with conventional formulations [levodopa and a dopa decarboxylase inhibitor (DDCI)], is associated with re-emergence of symptoms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d618ed7da409b56743e3a8fe5f554aeb
https://pubmed.ncbi.nlm.nih.gov/18582341
https://pubmed.ncbi.nlm.nih.gov/18582341
Publikováno v:
Revue neurologique. 164(4)
It has been known for more than 30 years that the efficiency of the dopaminergic treatments can wear off. Currently, motor fluctuations and especially non-motor fluctuations (dysautonomic, cognitive/psychiatric or sensory/pain) remain often underdiag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e734c42b016bda992cddaaf6bf46c041
https://pubmed.ncbi.nlm.nih.gov/18439927
https://pubmed.ncbi.nlm.nih.gov/18439927
Autor:
M A, Cordoliani, U, Michon-Pasturel, K, Rerat, J, Arvieux, E, Masy, E, Hachulla, P, Vermersch
Publikováno v:
La Revue de medecine interne. 19(9)
Although multiple sclerosis (MS) and antiphospholipid syndrome (AS) are usually defined by specific criteria that make them distinguishable, in some cases, transition between the two diseases based on clinical and brain imaging findings is not clear.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94c35bdffd80ac1f7826e985d3b4d149
https://pubmed.ncbi.nlm.nih.gov/9793150
https://pubmed.ncbi.nlm.nih.gov/9793150
Autor:
J.F. Doubrère, I. Vannier, R. Trèves, M. Mick, P. Bonduelle, K. Rerat, C. Brun-Srang, E. Serra
Publikováno v:
Douleurs : Evaluation - Diagnostic - Traitement. 7:104-105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15f59d122807f3b07febfbded94e8d94
https://doi.org/10.1016/s1624-5687(06)77900-8
https://doi.org/10.1016/s1624-5687(06)77900-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. de Seze, K Rerat, Patrick Vermersch, C Rose, J C Hache, Claude-Alain Maurage, S Blond, Tanya Stojkovic, C Daems-Monpeurt
Publikováno v:
La Revue de Médecine Interne. 19:173S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::958baee566db09a2edb8ebf81ddb1464
https://doi.org/10.1016/s0248-8663(98)80296-8
https://doi.org/10.1016/s0248-8663(98)80296-8